![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 11, 9831-9839, March 12, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




¶
From the
Departamento de Química Biológica de la Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires and CONICET, 1428 Buenos Aires, Argentina and
Centre de Regulació Genòmica, Barcelona, Spain
Bcl-X exists in at least five different isoforms with complex effects on programmed cell death. Glucocorticoids and progestins control bcl-X expression and influence the ratio between bcl-XL (antiapoptotic isoform) and bcl-XS (proapoptotic isoform) in different tissues. The 5'-UTR region of the mouse bcl-X gene contains at least five different promoters, which exhibit a tissue-specific pattern of promoter usage. Several mRNAs with different 5'-leading exons can be generated upon promoter activation. Here we explore the potential of the various bcl-X gene promoters to be regulated by glucocorticoids or progestins. We found that the region located immediately upstream of promoter 4 (P4) contains two hormone response element (HRE)-like sequences at positions 3040 (HRE I) and 3001 (HRE II) relative to the translation initiation codon. These HRE-like sequences confer hormone responsiveness to a core promoter and bind glucocorticoid or progesterone receptors in vitro. Point mutations of both HREs that prevent steroid receptor binding also eliminate hormonal inducibility. In cells treated with glucocorticoids, the hormone receptor is recruited to the P4 region containing the HREs. Analysis of the products of the endogenous bcl-X in epithelial mammary cells showed that only transcripts originating from P4 increased upon hormone treatment. This observation correlates with the induction of the bcl-XL mRNA, suggesting that P4 is one of the bcl-X promoters responsible for the generation of this antiapoptotic isoform.
Received for publication, November 12, 2003
* This research was supported by the University of Buenos Aires (X218), the fellowship "Arturo Oñativia-Ramón Carrillo" from Ministerio de Salud, Fundación Antorchas, and the Agencia Nacional de Promoción Científica y Tecnológica (PICT 0005-09044). Work at the Centre de Regulació Genòmica was supported by grants from the Ministerio de Ciencia y Tecnologia (PM 1999-0030) and from the Ministerio de Sanidad (SAF2001-0463). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Centre de Regulació Genòmica, Passeig Maritim 37-49, E-08003 Barcelona, Spain. Tel.: 34-93-224-09-01; Fax: 34-93-224-08-99; E-mail: miguel.beato{at}crg.es.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. Subtil-Rodriguez, L. Millan-Arino, I. Quiles, C. Ballare, M. Beato, and A. Jordan Progesterone Induction of the 11{beta}-Hydroxysteroid Dehydrogenase Type 2 Promoter in Breast Cancer Cells Involves Coordinated Recruitment of STAT5A and Progesterone Receptor to a Distal Enhancer and Polymerase Tracking Mol. Cell. Biol., June 1, 2008; 28(11): 3830 - 3849. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, G. Tsaprailis, and G. T. Bowden Nucleolin Stabilizes Bcl-XL Messenger RNA in Response to UVA Irradiation Cancer Res., February 15, 2008; 68(4): 1046 - 1054. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Revil, J. Toutant, L. Shkreta, D. Garneau, P. Cloutier, and B. Chabot Protein Kinase C-Dependent Control of Bcl-x Alternative Splicing Mol. Cell. Biol., December 15, 2007; 27(24): 8431 - 8441. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Carnevale, C. J. Proietti, M. Salatino, A. Urtreger, G. Peluffo, D. P. Edwards, V. Boonyaratanakornkit, E. H. Charreau, E. B. de Kier Joffe, R. Schillaci, et al. Progestin Effects on Breast Cancer Cell Proliferation, Proteases Activation, and in Vivo Development of Metastatic Phenotype All Depend on Progesterone Receptor Capacity to Activate Cytoplasmic Signaling Pathways Mol. Endocrinol., June 1, 2007; 21(6): 1335 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rocha-Viegas, G. P. Vicent, J. L. Baranao, M. Beato, and A. Pecci Glucocorticoids Repress bcl-X Expression in Lymphoid Cells by Recruiting STAT5B to the P4 Promoter J. Biol. Chem., November 10, 2006; 281(45): 33959 - 33970. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Presman, E. Hoijman, N. R. Ceballos, M. D. Galigniana, and A. Pecci Melatonin Inhibits Glucocorticoid Receptor Nuclear Translocation in Mouse Thymocytes Endocrinology, November 1, 2006; 147(11): 5452 - 5459. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Vitiello, R. J. Staversky, S. C. Gehen, C. J. Johnston, J. N. Finkelstein, T. W. Wright, and M. A. O'Reilly p21Cip1 Protection against Hyperoxia Requires Bcl-XL and Is Uncoupled from Its Ability to Suppress Growth Am. J. Pathol., June 1, 2006; 168(6): 1838 - 1847. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liao, S. Tang, J. B. Thrasher, T. L. Griebling, and B. Li Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer Mol. Cancer Ther., April 1, 2005; 4(4): 505 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. V. Delfino, M. Agostini, S. Spinicelli, P. Vito, and C. Riccardi Decrease of Bcl-xL and augmentation of thymocyte apoptosis in GILZ overexpressing transgenic mice Blood, December 15, 2004; 104(13): 4134 - 4141. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |